What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
BASG furthermore publishes the so-called RMS Flyer which inform about Austria's very successful activities as Reference Member State.
Since the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6) entered into force, the active use of the UPD for variations not requiring assessment (VNRA) is obligatory for the applicant / marketing
aMengenstromanalyseASP_DDD_DCD.xml , the EMA category, DDDvet and DCDvet values are included per active substance in addition to the marketing authorisation data of antibiotic-relevant veterinary medicinal
Wollein G. Assessment of immunoglobulin concentrates on thrombogenic activity by thrombin generation assay, prekallikrein activator assay, and size-exclusion chromatography. Transfusion. 2014 Feb;54(2):376-83
marketed medicinal products containing aluminium compounds have packaging information listing all active substances and excipients contained in the vaccine. To address the recurring question of the safety
carried out on the basis of the consent until the revocation. 11. Profiling The BASG does not engage in active profiling for automated decision making. 12. Modification of this data protection information We
Folder Facts | 332 KB 28/02/2017 MEA Folder 2018 Inhalt: AGES Medicines and Medical Devices Agency Activities and Locations Erscheinungsdatum: Jänner 2018 Sprache: Englisch Anzahl der Seiten : 6 Folder MEA
r_Tel Telephone number of marketing authorisation holder Grund Reason of the shortage Wirkstoffe Active substances
EMA - European Medicines Agency General page on the involvement of patients and consumers in the activities of the Agency: EMA interaction with patients and consumers To the website of the working group [...] Our misson is to be the voice of allergy, asthma and COPD patients at European level and to be actively involved in the decisions impacting their health. EFA EURORDIS - Rare Disease Patients in Europe